Characterization of a Gemcitabine-Resistant Murine Leukemic Cell Line-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of a Gemcitabine-Resistant Murine Leukemic Cell Line

Published:2004-08-15 Issue:16 Volume:10 Page:5614-5621
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Jordheim Lars Petter,Cros Emeline,Gouy Marie-Hélène,Galmarini Carlos M.,Peyrottes Suzanne,Mackey John,Perigaud Christian,Dumontet Charles

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phospholipid bioconjugation: advancements and applications in prodrug development and metabolic labeling;International Conference on Modern Medicine and Global Health (ICMMGH 2023);2023-09-07

2. Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers;Cancers;2021-02-25

3. Bladder Cancer Chemosensitivity Is Affected by Paraoxonase-2 Expression;Antioxidants;2020-02-20

4. Anti-tumor Activities of 3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors and Bisphosphonates in Pancreatic Cell Lines Which Show Poor Responses to Gemcitabine;Biological and Pharmaceutical Bulletin;2020-01-01

5. Molecular imaging of deoxycytidine kinase activity using deoxycytidine-enhanced CEST MRI;Cancer Research;2019-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP